RareDiseasesNews.net

Rare diseases Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "ATTR amyloidosis"

A study led by researchers from the Amyloidosis Center at Boston University School of Medicine ( BUSM ) and Boston Medical Center ( BMC ) has demonstrated that Diflunisal, a generic anti-inflammatory ...


HELIOS-A phase 3 study of Vutrisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated ( ATTR ) amyloidosis, met its primary and both secondary endpoints ...


Full positive results from the HELIOS-A phase 3 study of Vutrisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated ( ATTR ) amyloidosis, which met its ...